{Reference Type}: Journal Article
{Title}: Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling.
{Author}: Zhou J;Zhang M;Gao A;Herman JG;Guo M;
{Journal}: Epigenomics
{Volume}: 16
{Issue}: 13
{Year}: 2024 Jul 18
{Factor}: 4.357
{DOI}: 10.1080/17501911.2024.2370590
{Abstract}: Aim: The aim of current study is to explore the epigenetic changes and function of KCTD8 in human hepatocellular carcinoma (HCC). Materials & methods: HCC cell lines and tissue samples were employed. Methylation specific PCR, flow cytometry, immunoprecipitation and xenograft mouse models were used.Results: KCTD8 was methylated in 44.83% (104/232) of HCC and its methylation may act as an independent poor prognostic marker. KCTD8 expression was regulated by DNA methylation. KCTD8 suppressed HCC cell growth both in vitro and in vivo via inhibiting PI3K/AKT pathway.Conclusion: Methylation of KCTD8 is an independent poor prognostic marker, and epigenetic silencing of KCTD8 increases the malignant tendency in HCC.<BR>[Box: see text].